High Oct4 expression: implications in the pathogenesis of neuroblastic tumours.

These results suggest that the Oct4 gene may regulate NBT pathogenic differentiation pathways, and should thus be considered as a target for knockdown when developing novel therapies for high-risk NBT patients.